The Cannabis Conversation | Medical Cannabis | CBD | Hemp

EPISODE #193: Investment in the European Cannabis Industry with William Muecke & Daniel Grözinger

October 03, 2023 Anuj Desai with William Muecke & Daniel Grözinger Season 1 Episode 193
The Cannabis Conversation | Medical Cannabis | CBD | Hemp
EPISODE #193: Investment in the European Cannabis Industry with William Muecke & Daniel Grözinger
Show Notes

On the latest episode of The Cannabis Conversation, we speak with William Muecke of Artemis Growth Partners & Daniel Grözinger of Park Lane Capital.

We look at the European Cannabis Industry from an investment perspective, including the benefits of the legal cannabis market in Germany and France, the potential for mergers and acquisitions in Europe, and Will and Daniel’s thoughts on what’s needed to succeed in this sector in the next few years.

The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing.

Get in touch at
www.luminorecruit.com/


About William Muecke

Will Muecke is the Managing Member at Artemis Growth Partners, a private equity firm with $390 million in assets, specializing in ESG and impact investments within the global cannabis industry.

He also co-founded CoreCo Private Equity, an ESG-focused fund, recognized as a "Best for the World" fund in 2017, with backing from institutions like the IFC/World Bank and European family offices.

Previously, he served as global co-head of healthcare services at Goldman, Sachs & Co. in New York, with extensive networks across Europe, the United States, and Latin America. 

Currently, he holds the position of Chief Investment Officer at Artemis Growth Partners in London.


About Daniel Grözinger

Daniel Grözinger, a Partner at Parklane Capital in Germany, is a seasoned M&A expert with a focus on the tech sector. In 2021, he expanded his expertise into the cannabis market and played a pivotal role in the sale of Four 20 Pharma to Curaleaf in 2022.

With a background in over 75 M&A deals, Daniel is also a serial entrepreneur. Notably, he co-founded getgo.de, an online ticketing industry leader, and sold it to CTS Eventim AG. He then managed two business units at CTS, generating over 500 million EUR in revenue.

In 2003, he founded uniquedigital, a top-ranked online marketing agency, later acquired by Syzygy AG in 2008. Daniel has a history of founding and building customer-focused companies, including verwandt.de, Farbflut Entertainment, Emporis, and Animod, among others. He has also invested in various internet companies and startups as a business angel, including Prezi.com and Fiverr, before joining Parklane Capital in 2014.


Resources

Connect with William on LinkedIn: https://www.linkedin.com/in/wmuecke

Connect with Daniel on LinkedIn: https://www.linkedin.com/in/groezinger/

Artemis Growth Partners’ Website: www.artemisgrowth.com

Parklane Capital’s Website: